| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US5229137 (Pediatric) | J AND J CONSUMER INC | Methods and pharmaceutical compositions for treating episodic heartburn |
Nov, 2012
(11 years ago) | |
| US5989588 | J AND J CONSUMER INC | Methods and compositions for preventing and treating heartburn |
Sep, 2017
(6 years ago) | |
|
US5989588 (Pediatric) | J AND J CONSUMER INC | Methods and compositions for preventing and treating heartburn |
Mar, 2018
(6 years ago) | |
| US6814978 | J AND J CONSUMER INC | Process for preparing a soft tablet |
Aug, 2021
(2 years ago) | |
|
US6814978 (Pediatric) | J AND J CONSUMER INC | Process for preparing a soft tablet |
Feb, 2022
(2 years ago) | |
Pepcid Complete is owned by J And J Consumer Inc.
Pepcid Complete contains Calcium Carbonate; Famotidine; Magnesium Hydroxide.
Pepcid Complete has a total of 5 drug patents out of which 5 drug patents have expired.
Expired drug patents of Pepcid Complete are:
- US5229137*PED
- US5989588
- US5989588*PED
- US6814978
- US6814978*PED
Pepcid Complete was authorised for market use on 16 October, 2000.
Pepcid Complete is available in tablet, chewable;oral dosage forms.
Pepcid Complete can be used as method of use which is subject of the application.
The generics of Pepcid Complete are possible to be released after 26 February, 2022.
Drugs and Companies using CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE ingredient
Market Authorisation Date: 16 October, 2000
Treatment: Method of use which is subject of the application
Dosage: TABLET, CHEWABLE;ORAL
PEPCID COMPLETE family patents
